Liver Surgery
The First Affiliated Hospital of Nanjing Medical University
---- Damage control in liver surgery
---- Regulatory T cell and transplantation tolerance
---- Organ protection withcontinue machine perfusion
Education:
Visiting Scholar, 2013.08-2014.07, liver transplantation,University of California, Los Angeles, USA
Ph D,Surgery,2010, Nanjing Medical University, Nanjing, China
Post-Doctor, 2008.03-2010.06, Department of Immunology ,University of Southern California, USA
Master of Medicine,Surgery,2007, Nanjing Medical, University, Nanjing, China
Bachelor of Medicine, 2003,Clinical medicine, Nanjing Medical University, Nanjing, China
Honors and Awards:
2019, National talent project "outstanding contributions of young and middle-aged" experts
2018, Top 10 young stars of science and technology in jiangsu province
2017, Jiangsu youth May 4th medal
2017, Provincial science and technology progress award of Jiangsu
2017, Outstanding achievement award for scientific research in Universities
2017, The Chinese medical science and technology award
2017, The Huaxia medical science and technology award
Ongoing Research Projects:
PI, 2019.01, Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, CAMS(No. 2019-I2M-5-035)
PI, 2020.01, TAK1 promotes the progression of non-alcoholic steatohepatitis through YAP/c-Jun interaction in Kupffer cells, NSFC(No. 81971495)
PI, 2016.01, On transplantation immunology , NSFC(No. 81522020)
PI, 2016.01, On the mechanism of chronic rejection mediated by IL-17 with autoantigen ColΙ after liver transplantation, NSFC(No. 81571564)
Selected Papers:
1. Lu L, Joseph Barbi, Fan Pan. The regulation of immune tolerance by FOXP3. Nature Reviews Immunology. 2017 Nov;17(11):703-717. IF= 39.931
2. Ni X, Tao J, Barbi J, Chen Q2, Park BV, Li Z, Zhang N, Lebid A, Ramaswamy A, Wei P, Zheng Y, Zhang X, Wu X, gnali PDA, Yang C, Li H, PardollD, LuL, PanD, PanF.YAP is essential for Treg mediated suppression of anti-tumor immunity. Cancer Discovery. 2018 Aug;8(8):1026-1043. IF=20.01
3. Lu L, Yue S, Jiang L, Li C, Zhu Q, Ke M, Lu H, Wang X, Busuttil RW, Ying QL, Kupiec-Weglinski JW, Ke B. Myeloid Notch1 deficiency activates the RhoA/ROCK pathway and aggravates hepatocellular damage in mouse ischemic livers. Hepatology. 2018 Mar;67(3):1041-1055. IF=13.25
4. Lu Y, Hippen KL, Lemire AL, Gu J, Wang W, Ni X, Ranganathan P, Levine BL, Riley JL, June CH, Turka LA, Munn DH, Garzon R, Lu L(*); Blazar BR(*). miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potency. Blood. 2016, 128: 1424~1435. IF=13.164
5. Ni, XH, Kou, W, Gu, J, Wei, P, Wu, X, Peng, H, Tao, JH, Yan, W, Yang, XP, Lebid, A, Park, BV, Chen, ZJ, Tian, YZ, Fu, J, Newman, S, Wang, XM, Shen, HB, Li, B, Blazar, BR, Wang, XH, Barbi, J(*), Pan, F(*), Lu, L(*).TRAF6 directs FOXP3 localization and facilitates regulatory T-cell function through K63-linked ubiquitination. EMBO J. 2019 May 2;38(9). pii: e99766. IF=11.227
6.Lu L, Lan Q, Li Z, Zhou X, Gu J, Li Q, Wang J, Chen M, Liu Y, Shen Y, Brand DD, Ryffel B, Horwitz DA, Quismorio FP, Liu Z, Li B, Olsen NJ, Zheng SG. Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions. Proc Natl Acad Sci U S A. 2014; 111(33):E3432-40. IF=9.674